These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 12482878)
1. Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells. Podar K; Tai YT; Cole CE; Hideshima T; Sattler M; Hamblin A; Mitsiades N; Schlossman RL; Davies FE; Morgan GJ; Munshi NC; Chauhan D; Anderson KC J Biol Chem; 2003 Feb; 278(8):5794-801. PubMed ID: 12482878 [TBL] [Abstract][Full Text] [Related]
2. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. Tu Y; Gardner A; Lichtenstein A Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064 [TBL] [Abstract][Full Text] [Related]
3. Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected]. Abroun S; Ishikawa H; Tsuyama N; Liu S; Li FJ; Otsuyama K; Zheng X; Obata M; Kawano MM Blood; 2004 Mar; 103(6):2291-8. PubMed ID: 14592826 [TBL] [Abstract][Full Text] [Related]
4. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. Ushio-Fukai M; Hilenski L; Santanam N; Becker PL; Ma Y; Griendling KK; Alexander RW J Biol Chem; 2001 Dec; 276(51):48269-75. PubMed ID: 11585822 [TBL] [Abstract][Full Text] [Related]
5. Effect of cholesterol depletion on mitogenesis and survival: the role of caveolar and noncaveolar domains in insulin-like growth factor-mediated cellular function. Matthews LC; Taggart MJ; Westwood M Endocrinology; 2005 Dec; 146(12):5463-73. PubMed ID: 16166225 [TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 is required for vascular endothelial growth factor-triggered multiple myeloma cell migration and is targeted by bortezomib. Podar K; Shringarpure R; Tai YT; Simoncini M; Sattler M; Ishitsuka K; Richardson PG; Hideshima T; Chauhan D; Anderson KC Cancer Res; 2004 Oct; 64(20):7500-6. PubMed ID: 15492276 [TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 as a potential new therapeutic target in multiple myeloma. Podar K; Anderson KC Cancer Lett; 2006 Feb; 233(1):10-5. PubMed ID: 16473666 [TBL] [Abstract][Full Text] [Related]
8. Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells. Podar K; Mostoslavsky G; Sattler M; Tai YT; Hayashi T; Catley LP; Hideshima T; Mulligan RC; Chauhan D; Anderson KC J Biol Chem; 2004 May; 279(20):21658-65. PubMed ID: 15010462 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I activation of Akt survival cascade in neuronal cells requires the presence of its cognate receptor in caveolae. Lu X; Kambe F; Cao X; Yamauchi M; Seo H Exp Cell Res; 2008 Jan; 314(2):342-51. PubMed ID: 18022157 [TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling. Ravid D; Maor S; Werner H; Liscovitch M Oncogene; 2005 Feb; 24(8):1338-47. PubMed ID: 15592498 [TBL] [Abstract][Full Text] [Related]
11. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650 [TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Sedding DG; Hermsen J; Seay U; Eickelberg O; Kummer W; Schwencke C; Strasser RH; Tillmanns H; Braun-Dullaeus RC Circ Res; 2005 Apr; 96(6):635-42. PubMed ID: 15731459 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. Ge NL; Rudikoff S Blood; 2000 Oct; 96(8):2856-61. PubMed ID: 11023522 [TBL] [Abstract][Full Text] [Related]
14. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway. Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867 [TBL] [Abstract][Full Text] [Related]
15. Modulation of caveolin-1 expression can affect signalling through the phosphatidylinositol 3-kinase/Akt pathway and cellular proliferation in response to insulin-like growth factor I. Matthews LC; Taggart MJ; Westwood M Endocrinology; 2008 Oct; 149(10):5199-208. PubMed ID: 18583416 [TBL] [Abstract][Full Text] [Related]
16. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration. Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the caveolin-3 and Akt status in caveolae by insulin resistance in H9c2 cardiomyoblasts. Ha H; Pak Y Exp Mol Med; 2005 Jun; 37(3):169-78. PubMed ID: 16000870 [TBL] [Abstract][Full Text] [Related]
18. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications. Mitsiades CS; Mitsiades N; Poulaki V; Schlossman R; Akiyama M; Chauhan D; Hideshima T; Treon SP; Munshi NC; Richardson PG; Anderson KC Oncogene; 2002 Aug; 21(37):5673-83. PubMed ID: 12173037 [TBL] [Abstract][Full Text] [Related]
20. Promotion of human mesenchymal stem cell osteogenesis by PI3-kinase/Akt signaling, and the influence of caveolin-1/cholesterol homeostasis. Baker N; Sohn J; Tuan RS Stem Cell Res Ther; 2015 Dec; 6():238. PubMed ID: 26626726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]